Isaac Dingle, MD
Otolaryngology · Charlotte, NCNPI 1306196266
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 52 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Optinose US, Inc. at 24.2% of the total.
Across 52 payments — averaging $22.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$281
- Sanofi$246
- Harrow Eye, LLC$110
- Amgen$85
- Smith+Nephew$79
- Stryker$65
- plus $292 from 9 others
What the payments were for
- Food & beverage$1,11496%
- Education$454%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 15 | $281 |
| Sanofi | 9 | $246 |
| Harrow Eye, LLC | 4 | $110 |
| Amgen | 4 | $85 |
| Smith+Nephew | 3 | $79 |
| Stryker | 2 | $65 |
| Bausch & Lomb Americas Inc. | 3 | $65 |
| Alk-abello, Inc | 3 | $46 |
| Acclarent, Inc | 2 | $41 |
| Kaleo, Inc. | 2 | $35 |
| Merck | 1 | $33 |
| Hikma Pharmaceuticals USA | 1 | $23 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Davol Inc. | 1 | $16 |
| Medtronic | 1 | $15 |
How this compares
$1,159 in reported general payments places this provider in the 55th percentile of 362 otolaryngology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 307 | $4,852 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,510 |
| Ipratropium Bromide | 104 | $2,916 |
| Dexamethasone Sodium Phosphate | 36 | $1,492 |
| Azelastine Hcl | 61 | $1,320 |
| Rabeprazole Sodium | 34 | $950 |
| Fluocinolone Acetonide Oil | 17 | $928 |
| Cefdinir | 28 | $732 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 62 | $608 |
| Ciprofloxacin Hcl | 61 | $546 |
| Mupirocin | 64 | $477 |
| Doxycycline Monohydrate | 34 | $417 |
| Prednisone | 142 | $269 |
| Pantoprazole Sodium | 23 | $211 |
| CefuroximeCefuroxime Axetil | 14 | $190 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Charlotte
- Brendan O ConnellCharlotte$28K
- Zachary CappelloCharlotte$23K
- Michael SicardCharlotte$17K
- Hunter HooverCharlotte$15K
- Douglas VillaretCharlotte$7K
- Joshua LevineCharlotte$6K
- Daron SmithCharlotte$4K
- Tyler JanzCharlotte$4K
- David JangDurham$324K
- Robert FerrisRaleigh$258K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.